麻豆传媒

Health news and commentary gathered by 麻豆传媒 staff

Secondary analysis of trial data consistent with observational studies

Its disparate impact offers lessons in resource sharing and medical ethics

The amount of vaccine to order is "a guess," says one physician

Also in TTHealthWatch: beta-blockers after MI

Paul Offit, MD, talks about the flu, RSV, and COVID vaccines for the 2024-2025 season

Governments are slashing budgets that feed local health departments

Unlike the mRNA vaccines, protein-based vaccine targets JN.1 strain

Immediate clinical application is unclear, but prototype shows potential

Also in TTHealthWatch: myocarditis after COVID vaccination

Non-cardiovascular benefits observed in SELECT trial

Multiple cases reported on social media; few precautions in evidence at the convention

IOC data show "about a 10% infection rate in those who swam in the Seine"

Pemivibart may have reduced activity against growing variant KP.3.1.1, agency warns